Skip to main content
Erschienen in: Archives of Dermatological Research 7/2021

06.08.2020 | Concise Communication

A strategy for empowering clinicians and increasing innovation: the Magic Wand Initiative

verfasst von: Lilit Garibyan, Daniela Kroshinsky, Esther Freeman, Fernanda H. Sakamoto, Richard Rox Anderson

Erschienen in: Archives of Dermatological Research | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Clinicians play a critical role in recognizing, initiating, and adopting innovative solutions to clinical problems. Increasing clinician involvement in problem-based innovation will help identify and solve unmet medical needs. The overall objective of our program was to increase clinician involvement in problem-based innovation. We pioneered and piloted the “Magic Wand” Initiative (MWI) at Massachusetts General Hospital Department of Dermatology, by inviting clinical faculty to voluntarily participate in problem-driven innovation. The primary outcome was the number of unmet clinical needs identified and pursued by clinicians, who were ‘activated’ to initiate problem-based innovation. Other objectives were to enhance clinician-to-clinician dialogue and to develop specific strategic framework for clinician-led, problem-driven research. This pilot MWI was started in 2013 with an announcement at dermatology faculty meeting inviting all clinical faculty to participate on volunteer basis. Academic dermatologists were the main participants in this program. They also contacted, collaborated and worked with research faculty, industry experts and lawyers. Out of 30 unmet needs identified by clinicians participating in MWI, eight are actively being pursued by clinicians. Three of those cases presented here have achieved publications, grant funding, prototype devices and product for patient use. In conclusion, MWI is an innovative approach that educates and equips clinician to identify and solve problems and engages them as leaders in their healthcare ecosystem. MWI has achieved concrete measurable success, affirming that if clinicians are empowered and supported to identify and solve existing unmet medical problems, new and innovative solutions can be invented to improve patient care.
Literatur
1.
Zurück zum Zitat Zuckerman B, Margolis PA, Mate KS (2013) Health services innovation: the time is now. JAMA 309(11):1113–1114CrossRef Zuckerman B, Margolis PA, Mate KS (2013) Health services innovation: the time is now. JAMA 309(11):1113–1114CrossRef
3.
Zurück zum Zitat Garibyan L, Anderson RR (2017) Increasing clinical faculty engagement in problem-driven research: the "magic wand" initiative at massachusetts general hospital. JAMA Dermatol 153(5):375–376CrossRef Garibyan L, Anderson RR (2017) Increasing clinical faculty engagement in problem-driven research: the "magic wand" initiative at massachusetts general hospital. JAMA Dermatol 153(5):375–376CrossRef
4.
Zurück zum Zitat Raff AB, Kroshinsky D (2016) Cellulitis: a review. JAMA 316(3):325–337CrossRef Raff AB, Kroshinsky D (2016) Cellulitis: a review. JAMA 316(3):325–337CrossRef
5.
Zurück zum Zitat Strazzula L et al (2015) Inpatient dermatology consultation aids diagnosis of cellulitis among hospitalized patients: a multi-institutional analysis. J Am Acad Dermatol 73(1):70–75CrossRef Strazzula L et al (2015) Inpatient dermatology consultation aids diagnosis of cellulitis among hospitalized patients: a multi-institutional analysis. J Am Acad Dermatol 73(1):70–75CrossRef
6.
Zurück zum Zitat St John J et al (2018) Estimating the health care costs associated with recurrent cellulitis managed in the outpatient setting. J Am Acad Dermatol 78(4):749–753CrossRef St John J et al (2018) Estimating the health care costs associated with recurrent cellulitis managed in the outpatient setting. J Am Acad Dermatol 78(4):749–753CrossRef
7.
Zurück zum Zitat Ko LN et al (2018) Effect of dermatology consultation on outcomes for patients with presumed cellulitis: a randomized clinical trial. JAMA Dermatol 154(5):529–536CrossRef Ko LN et al (2018) Effect of dermatology consultation on outcomes for patients with presumed cellulitis: a randomized clinical trial. JAMA Dermatol 154(5):529–536CrossRef
8.
Zurück zum Zitat Ko LN et al (2018) Skin surface temperatures measured by thermal imaging aid in the diagnosis of cellulitis. J Invest Dermatol 138(3):520–526CrossRef Ko LN et al (2018) Skin surface temperatures measured by thermal imaging aid in the diagnosis of cellulitis. J Invest Dermatol 138(3):520–526CrossRef
9.
Zurück zum Zitat Ko LN et al (2018) Clinical usefulness of imaging and blood cultures in cellulitis evaluation. JAMA Intern Med 178(7):994–996CrossRef Ko LN et al (2018) Clinical usefulness of imaging and blood cultures in cellulitis evaluation. JAMA Intern Med 178(7):994–996CrossRef
10.
Zurück zum Zitat Brown DN, Langan SM, Freeman EE (2017) Task shifting in dermatology: a call to action. JAMA Dermatol 153(11):1179–1180CrossRef Brown DN, Langan SM, Freeman EE (2017) Task shifting in dermatology: a call to action. JAMA Dermatol 153(11):1179–1180CrossRef
12.
Zurück zum Zitat Freeman EE et al (2018) Smartphone confocal microscopy for imaging cellular structures in human skin in vivo. Biomed Opt Express 9(4):1906–1915CrossRef Freeman EE et al (2018) Smartphone confocal microscopy for imaging cellular structures in human skin in vivo. Biomed Opt Express 9(4):1906–1915CrossRef
13.
Zurück zum Zitat Lyons JJ, Milner JD, Stone KD (2015) Atopic dermatitis in children: clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am 35(1):161–183CrossRef Lyons JJ, Milner JD, Stone KD (2015) Atopic dermatitis in children: clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am 35(1):161–183CrossRef
14.
Zurück zum Zitat Kraft MT, Prince BT (2019) Atopic dermatitis is a barrier issue, not an allergy issue. Immunol Allergy Clin North Am 39(4):507–519CrossRef Kraft MT, Prince BT (2019) Atopic dermatitis is a barrier issue, not an allergy issue. Immunol Allergy Clin North Am 39(4):507–519CrossRef
15.
Zurück zum Zitat Elias PM (2008) Skin barrier function. Curr Allergy Asthma Rep 8(4):299–305CrossRef Elias PM (2008) Skin barrier function. Curr Allergy Asthma Rep 8(4):299–305CrossRef
16.
17.
Zurück zum Zitat Bouthillette M et al (2019) A crosslinked polymer skin barrier film for moderate to severe atopic dermatitis: a pilot study in adults. J Am Acad Dermatol 71:116–132 Bouthillette M et al (2019) A crosslinked polymer skin barrier film for moderate to severe atopic dermatitis: a pilot study in adults. J Am Acad Dermatol 71:116–132
Metadaten
Titel
A strategy for empowering clinicians and increasing innovation: the Magic Wand Initiative
verfasst von
Lilit Garibyan
Daniela Kroshinsky
Esther Freeman
Fernanda H. Sakamoto
Richard Rox Anderson
Publikationsdatum
06.08.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 7/2021
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-020-02111-z

Weitere Artikel der Ausgabe 7/2021

Archives of Dermatological Research 7/2021 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.